Are ACE inhibitors and angiotensin receptor blockers useful in the treatment of atrial fibrillation?
Raatikainen, M.J.; Huikuri, H.V.
Duodecim; Laaketieteellinen Aikakauskirja 119(16): 1505-1507
2003
ISSN/ISBN: 0012-7183 PMID: 14535023 Document Number: 554995
Document emailed within 1 workday
Related Documents
Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin converting enzyme inhibitors and angiotensin Ii receptor blockers on angiogenesis of gastric cancer in a nude mouse model Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 565-568
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin-converting enzyme inhibitors and angiotensin Ii type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model Chinese Medical Journal 121(21): 2167-2171
Vijan, S.G. 2009: Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients Journal of the Indian Medical Association 107(3): 178-182
Spinar, J.; Vítovec, J.; Soucek, M.; Dusek, L.; Pavlík, T. 2009: CORD: COmparsion of Recommended Doses of ACE inhibitors and angiotensin Ii receptor blockers Vnitrni Lekarstvi 55(5): 481-488
Jiang, H.; Ma, L.-J.; Cong, H.-L.; Jiang, N.; Mao, Y.-M.; Xu, M.-L.; Cui, R.-Z. 2009: Expression of angiotensin Ii receptor subtypes in atrial fibrillation underlying rheumatic heart disease Zhonghua Nei Ke Za Zhi 48(7): 535-538
Cox, J.L.; Schuessler, R.B.; Boineau, J.P. 1991: The surgical treatment of atrial fibrillation. I. Summary of the current concepts of the mechanisms of atrial flutter and atrial fibrillation Journal of Thoracic and Cardiovascular Surgery 101(3): 402-405
Ol'binskaia, L.I.; Morozov, I.A. 1996: Angiotensin-Ii receptor blockers in the treatment of arterial hypertension Eksperimental'naia i Klinicheskaia Farmakologiia 59(5): 76-80
Schiffrin, E.L. 2002: Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers Canadian Journal of Cardiology 18 Suppl A: 15a-18a
Cox, J.L.; Canavan, T.E.; Schuessler, R.B.; Cain, M.E.; Lindsay, B.D.; Stone, C.; Smith, P.K.; Corr, P.B.; Boineau, J.P. 1991: The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation Journal of Thoracic and Cardiovascular Surgery 101(3): 406-426
Aoyama, N. 2007: Effect of combination therapy with angiotensin Ii type i receptor and aldosterone receptor blockers in heart failure Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 5): 145-149
de la Fuente Cid, R.; Varela Román, A. 2007: Which is the role of the angiotensin II receptor blockers (ARBs) for the treatment of heart failure? Do we work based on evidence/recommendations or pharmaceutical industry pressure? Anales de Medicina Interna 24(12): 607-609
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422
Charantharayil Gopalan, B.; Namboodiri, N.; Abdullakutty, J.; Lip, G.Y.; Koshy, A.G.; Krishnan Nair, V.; Babu, S.; Muhammed, S.; Azariah, J.L.; George, R.; Nambiar, A.; Govindan, U.; Zachariah, G.; Kumaraswamy, N.; Chakanalil Govindan, S.; Natesan, S.; Roby, A.; Velayudhan Nair, K.; Pillai, A.M.; Daniel, R.; Jayagopal, P.B.; Punnose, E.; Joseph, J.; Joseph, S.; Eapen, K.; Ram, R.; Mathew, C.; Faizal, A.; Issac, B.; Renga, S.; Menon, J.; Harikrishna, D.; Suresh, K.; Nair, T.; Susanth, S.S.; Kumar, R.A.; Abilash, T.P.; Sreekala, P.; Rajeev, E.; Raj, A.; Naik, R.; Rajalekshmi; Gopinath, A.; Binu, R.; Chacko, J.; Iqbal, P.T.; Sudhir, N.M.; Sreedharan, M.; Balakrishnan, N.; Musthaffa, M.; Jayakumar, B.; George, S.; Kumar, A.; Mathew, T.; Pramod, 2019: Kerala Atrial Fibrillation Registry: a prospective observational study on clinical characteristics, treatment pattern and outcome of atrial fibrillation in Kerala, India, cohort profile Bmj Open 9(7): E025901
Lommi, J. 2005: Angiotensin II-receptor blockers Duodecim; Laaketieteellinen Aikakauskirja 121(6): 589-592
Yamashita, T. 2007: Atrial fibrillation and renin-angiotensin system Nihon Rinsho. Japanese Journal of Clinical Medicine 65(3): 569-574
Wiecek, A. 1992: Effect of calcium channel blockers and angiotensin i converting enzyme inhibitors on the kidney Polski Tygodnik Lekarski 47(49-50): 1115-1117
Fruhwald, F.M.; Kickenweiz, E.; Zweiker, R.; Klein, W. 2001: Angiotensin i receptor blockers for heart failure Wiener Medizinische Wochenschrift 151(7-8): 157-159